Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Delivery: Overview01:16

Drug Delivery: Overview

422
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
422
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

467
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
467
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

827
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
827
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport01:23

Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport

788
Drugs need to permeate cell membranes to reach their target sites after administration. Orally administered drugs must transcend intestinal epithelial membrane barriers to infiltrate the systemic circulation. Drugs with a molecular weight of less than 500 Daltons diffuse through gaps between neighboring cells, called paracellular pathways.
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
788
Drug Delivery: Enteral Route01:18

Drug Delivery: Enteral Route

709
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
709
Prodrugs01:30

Prodrugs

2.8K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
2.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A nuclear delivery strategy for curative treatment of COPD using 1α,25-dihydroxyvitamin D3 and lipid nanoparticles.

The Journal of steroid biochemistry and molecular biology·2026
Same author

GLP-1 derivatives with functional sequences transit and migrate through trigeminal neurons.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2024
Same author

Characterization of a spontaneous mouse model of mild, accelerated aging via ECM degradation in emphysematous lungs.

Scientific reports·2023
Same author

Intracellular Drug Delivery Process of Am80-Encapsulated Lipid Nanoparticles Aiming for Alveolar Regeneration.

Pharmaceuticals (Basel, Switzerland)·2023
Same author

Am80-Encapsulated Lipid Nanoparticles, Developed with the Aim of Achieving Alveolar Regeneration, Have an Improvement Effect on Pulmonary Emphysema.

Pharmaceutics·2023
Same author

Involvement of trigeminal axons in nose-to-brain delivery of glucagon-like peptide-2 derivative.

Journal of controlled release : official journal of the Controlled Release Society·2022
Same journal

[Effect of Application Device Design on Scalp Delivery of Topical Minoxidil Formulations].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·2026
Same journal

[Survey of Pharmaceutical Interventions in Outpatient Cancer Chemotherapy].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·2026
Same journal

Effects of Fluctuating Triglyceride Levels on Initial and Steady-state Serum Amiodarone Concentrations in Japanese Patients: A Retrospective Study.

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·2026
Same journal

[Dynamic Oligomerization Processes and Functional Characterization of Bacterial ClpP Protease].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·2026
Same journal

[Structural Analysis Using Cryo-electron Microscopy for Protein-based Drug Design].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·2026
Same journal

[Expansion of Targeted Protein Degradation for Targeting Aggregate-prone Proteins and Mitochondrial Proteins].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·2026
查看所有相关文章

相关实验视频

Updated: Sep 9, 2025

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

7.7K

[基于新概念的药物输送系统的开发]

Chikamasa Yamashita1

  • 1Department of Pharmaceutics and Drug Delivery, Faculty of Pharmaceutical Sciences, Tokyo University of Science.

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
|August 31, 2025
PubMed
概括
此摘要是机器生成的。

这篇综述强调了40年的制药研究,重点是创新的药物输送系统. 主要发展包括新型吸入,COPD和阿尔茨海默氏症

关键词:
鼻子到大脑轴突运输慢性阻塞性肺部疾病干蛋糕吸入方式脂质纳米粒子

更多相关视频

Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers
18:57

Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers

Published on: October 17, 2013

46.6K
Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

16.0K

相关实验视频

Last Updated: Sep 9, 2025

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

7.7K
Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers
18:57

Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers

Published on: October 17, 2013

46.6K
Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

16.0K

科学领域:

  • 制药科学
  • 药物输送系统
  • 复原医学

背景情况:

  • 在东京药业有限公司和东京科学大学进行了40年的研发工作.
  • 专注于临床意义和新的药物输送系统概念,挑战传统思维.

研究的目的:

  • 总结关键的研究项目及其药物输送的创新方法.
  • 展示以患者为中心的吸入系统,慢性阻塞性肺病 (COPD) 治疗和阿尔茨海默病治疗方法的进步.

主要方法:

  • 从患者的角度来看,开发一种新型的吸入系统来输送蛋白质.
  • 使用脂质纳米颗粒的核转移策略用于COPD的气泡再生.
  • 设计用于阿尔茨海默病药物开发的糖化鼻至脑系统.

主要成果:

  • 一个以患者为中心的蛋白质吸入系统的概念化和描述.
  • 建议一种涉及气泡再生的COPD激进治疗策略.
  • 开发一种专门的系统,通过鼻子向大脑输送阿尔茨海默病治疗药物.

结论:

  • 研究表明,通过创新药物提供来解决临床需求的持续承诺.
  • 描述的系统代表了重要的概念转变,超越了传统的制药方法.
  • 未来用于COPD和阿尔茨海默病的治疗药物可能会从这些新的输送策略中受益.